Screenshots
About VLA1553: 302

Clinical Trial Study App for the Valneva VLA1553-302 Vaccine study. This is a study to demonstrate lot-to-lot consistency of three lots of a live-attenuated Chikungunya virus. the app enables study participants to complete eDiary entries, view scheduled appointments, conduct video consultations, and access resources about the study.

Additional Information
Version
1.0.2 (89.1 MB)
Updated
Jan 27, 2021
Age
12+ Years
First Released
Jan 10, 2021
Category
App Store ID
Available on
Write a review